Humacyte Inc Warrant
HUMAW
12 hedge funds and large institutions have $1.49M invested in Humacyte Inc Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.
20% less funds holding
Funds holding: 15 → 12 (-3)
36% less capital invested
Capital invested by funds: $2.33M → $1.49M (-$839K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RL
RPO LLC
Stamford,
Connecticut
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$342K |
| 2 |
ICM
Ionic Capital Management
New York
|
-$229K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$38.3K |
| 4 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$36K |
| 5 |
VF
Virtu Financial
New York
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $517K | -$38.3K | -22,694 | -8% |
|
|
LP
2
LMR Partners
London,
United Kingdom
| $353K | – | – | – |
|
|
RL
3
RPO LLC
Stamford,
Connecticut
| $159K | +$138K | +81,705 | New |
|
4
Jane Street
New York
| $110K | -$1.01K | -600 | -1% |
|
|
SCM
5
Sio Capital Management
New York
| $97K | – | – | – |
|
|
HF
6
HRT Financial
New York
| $96K | -$5.11K | -3,024 | -6% |
|
|
EAM
7
Exos Asset Management
New York
| $53K | – | – | – |
|
|
DCP
8
Diameter Capital Partners
New York
| $37K | -$8.06K | -4,772 | -20% |
|
|
PSAMP
9
P. Schoenfeld Asset Management (PSAM)
New York
| $37K | – | – | – |
|
10
Verition Fund Management
Greenwich,
Connecticut
| $29K | – | – | – |
|
11
Morgan Stanley
New York
| $1K | – | – | – |
|
|
AGM
12
Alpine Global Management
New York
| $91 | – | – | – |
|
|
13
LPL Financial
San Diego,
California
| – | -$342K | -149,792 | Closed |
|
|
ICM
14
Ionic Capital Management
New York
| – | -$229K | -100,389 | Closed |
|
|
ICMH
15
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$36K | -15,830 | Closed |
|
|
VF
16
Virtu Financial
New York
| – | -$24K | -10,314 | Closed |
|
HUMAW Hedge Fund Activity: Q1 2022 in Review
12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q1 2022, worth a combined $1.49M — down 36% from $2.33M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of HUMAW and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was RPO LLC, opening a new position worth an estimated $138K. The largest seller was LPL Financial, exiting entirely with an estimated $342K sold.
- 12 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q1 2022, down from 15 in Q4 2021.
- Funds reported $1.49M of Humacyte Inc Warrant stock for Q1 2022, down 36% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q1 2022 and 4 closed out, a net change of -3 holders.
- The largest Humacyte Inc Warrant buyer in Q1 2022 was RPO LLC, an estimated $138K added.
- The largest Humacyte Inc Warrant seller in Q1 2022 was LPL Financial, an estimated $342K sold.
Based on aggregated 13F filings for Q1 2022.